Larimar Therapeutics Inc
LRMR
Get informed when a big investor buys or sells
+ FollowMarket Cap$416.57M
Close$
$1.12
70.9% downside
Current Fair Value
70.9% downsideOvervalued by 70.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $416.57 Million |
|---|---|
| Enterprise Value | $328.84 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-2.27 |
| Beta | 0.75 |
| Outstanding Shares | 103,882,937 |
Return
| Return on Equity | -135.50% |
|---|---|
| Return on Assets | -104.42% |
| Return on Invested Capital | -135.29% |
Valuation & Multiples
| P/E Ratio | -2.02 |
|---|---|
| PEG | -7.99 |
| Price to Sales | - |
| Price to Book Ratio | 3.83 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -1.85 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.02 |
| Debt to Equity | 0.04 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 13, 2026
EPS Estimate
$-0.39
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
November 5, 2026
EPS Estimate
$-0.39
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.6478▲ 52.66% |
|---|---|
| Total Calls | 477,000▲ 230.33% |
| Total Puts | 309,000▲ 1665.71% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 103.02%▲ 3.35% |
|---|---|
| Total Invested | $394.80M▲ 42.52% |
| Investors Holding | 170▲ 32.00% |
ESG Score
No data